Company Filing History:
Years Active: 2019-2024
Title: The Innovations of Neal Cheng
Introduction
Neal Cheng is a prominent inventor based in Emeryville, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody agents. With a total of 2 patents to his name, Cheng's work focuses on innovative solutions for medical challenges.
Latest Patents
Cheng's latest patents include groundbreaking research on antibody agents specific for human CD19. These patents describe human antibody agents and multi-specific binding agents that specifically bind to native human CD19. The methods outlined in these patents are aimed at the detection, prevention, and therapeutic treatment of diseases characterized by CD19 expression, particularly B cell lymphomas and leukemias.
Career Highlights
Neal Cheng is currently associated with Eureka Therapeutics, Inc., where he continues to push the boundaries of medical research. His work has garnered attention for its potential impact on cancer treatment and diagnostics.
Collaborations
Cheng collaborates with notable colleagues, including Hong Liu and Jingwei Lu, who contribute to the innovative environment at Eureka Therapeutics, Inc.
Conclusion
Neal Cheng's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His work on antibody agents specific for human CD19 represents a significant step forward in the fight against cancer.